Latest featured videos from Journal-News.com
Clinical Trials Update: Nov. 4, 2009

Clinical Trials Update: Nov. 4, 2009

Related News from HealthDay
Trial Data on Anti-Seizure Drug Might Have Been Manipulated: Report
Clinical Trials Update: Nov. 11, 2009
Clinical Trials Update: Nov. 10, 2009
Clinical Trials Update: Nov. 9, 2009
Clinical Trials Update: Nov. 6, 2009
Clinical Trials Update: Nov. 5, 2009
Health News Archives
   

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Hepatitis C

This study will evaluate the safety and effectiveness of an investigational medication to treat chronic hepatitis C genotype 1 infection.

The research site is in Los Angeles, Calif.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/hepatitis.aspx.

-----

Osteoarthritis of the Hip or Knee

This study will evaluate a medication designed to ease osteoarthritis pain in the hip or knee. You must be aged 18 to 78 to qualify.

The research site is in Atlanta, Ga.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/osteoarthritis.aspx.

-----

Ankle Sprain

If you have hurt your ankle within the past 48 hours, you may qualify for this study of an investigational pain patch. Participants will have a 50/50 chance of receiving the actual patch or a placebo patch.

The research site is in Dallas, Texas.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/sprain.aspx.

-----

Copyright 2009 ClinicalConnection.com. All rights reserved.

 

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Home | News | Sports | Entertainment | Opinion | Life | Recreation | Jobs | Cars | Homes
Advertising Media Kit | Online Ad Studio | Advertiser Tools | Customer Service | Our Partners | RSS | Site Map

Copyright © 2009 Cox Ohio Publishing, Dayton, Ohio, USA. All rights reserved.

By using this site, you accept the terms of our Visitors Agreement and Privacy Policy. You may wish to note our other business policies.

This website is ACAP-enabled